Antibody-mediated cell depletion therapies in multiple sclerosis.

Front Immunol · 2022 · PMC9511140 · PMID 36172350

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Aligned with this observation, CD4+CD25+CD127+foxP3-Teff cells were recently suggested as a possible marker for monitoring disease activity, as patients with stable disease showed a trend for reduced levels of such population, with reduced Teff: Treg ratios ( 49 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.